Related Experiment Videos
Human cells as a source of interferons for clinical use
1Wellcome Biotechnology Ltd., Beckenham, Kent, England.
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Are all type I human interferons equivalent?
Journal of viral hepatitis·1998
The safety of biopharmaceutical products--a personal viewpoint.
Developments in biological standardization·1996
Cytokines in the treatment of virus infections.
Biotherapy (Dordrecht, Netherlands)·1994
Antibodies in patients with recurrent respiratory papillomatosis treated with lymphoblastoid interferon.
The Journal of laboratory and clinical medicine·1991
Detection and incidence of neutralizing antibodies to interferon-alpha-n1.
Journal of interferon research·1989
Rapid activation of the interferon-gamma signal transduction pathway by inhibitors of tyrosine phosphatases.
Journal of interferon research·1994
Interferon-alpha-induced biologic modifications in patients with chronic myelogenous leukemia.
Journal of interferon research·1994
Modulation of peripheral leukocyte counts and bone marrow function in mice by oral administration of interleukin-2.
Journal of interferon research·1994
IDO mutants cross resistant to type I interferon retain p91-dependent gene induction.
Journal of interferon research·1994
Interferon-alpha 2 produced by normal human leukocytes is predominantly interferon-alpha 2b.
Journal of interferon research·1994
Silver Needle Thermotherapy Regulates TRPV1 to Alleviate Endoplasmic Reticulum Stress and Relieve Myofascial Pain.
Journal of pain research·2026
Drug-coated balloon (SeQuent please neo) versus drug-eluting stent treatment for acute ST-elevation myocardial infarction: Design and rationale of the STEMI DCB trial.
Cardiovascular revascularization medicine : including molecular interventions·2026
Clinical relevance of TCI score-based refinement of conditioning intensity in cord blood transplantation for myelodysplastic syndrome.
Transplantation and cellular therapy·2026